Allakos Inc.
ALLKNASDAQHealthcare
$0.33
+$0.00(+0.22%)
Market Cap$29743071
P/E Ratio—
52W High$1.56
52W Low$0.22
Allakos Inc. (ALLK) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALLK · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: May 7, 2025EPS Actual
-$0.29
Est. -$0.26 · -11.5%
Revenue
—
Fiscal Period
Q2 FY2025
FY ends December
Report Date
May 7, 2025
After Market Close
▼ Miss EPS
ALLK reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2025 | Nov 4, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Aug 6, 2025 | -$0.24 | — | — | — | — | — |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.26 | -$0.29 | -11.5% | — | — | — |
| ▲ Q1 FY2025 | Mar 12, 2025 | -$0.21 | $0.00 | +102.0% | — | — | — |
| ▲ Q4 FY2024 | Nov 6, 2024 | -$0.22 | -$0.21 | +4.5% | — | — | — |
| ▲ Q3 FY2024 | Aug 7, 2024 | -$0.32 | -$0.30 | +6.3% | — | — | — |
| ▼ Q2 FY2024 | May 9, 2024 | -$0.41 | -$0.50 | -21.9% | — | — | — |
| ▼ Q1 FY2024 | Mar 14, 2024 | -$0.53 | -$0.71 | -34.0% | $0.01B | — | — |
Q4 FY2025
Nov 4, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 6, 2025
EPS Actual
—
EPS Est.
-$0.24
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$0.29
EPS Est.
-$0.26
EPS Surpr.
-11.5%
Revenue
—
Q1 FY2025
Mar 12, 2025Beat
EPS Actual
$0.00
EPS Est.
-$0.21
EPS Surpr.
+102.0%
Revenue
—
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
-$0.21
EPS Est.
-$0.22
EPS Surpr.
+4.5%
Revenue
—
Q3 FY2024
Aug 7, 2024Beat
EPS Actual
-$0.30
EPS Est.
-$0.32
EPS Surpr.
+6.3%
Revenue
—
Q2 FY2024
May 9, 2024Miss
EPS Actual
-$0.50
EPS Est.
-$0.41
EPS Surpr.
-21.9%
Revenue
—
Q1 FY2024
Mar 14, 2024Miss
EPS Actual
-$0.71
EPS Est.
-$0.53
EPS Surpr.
-34.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q3 FY2026 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q2 FY2026 | $-0.22 | $-0.22 | $-0.22 | 1 |
| Q1 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2025 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q3 FY2025 | $-0.02 | $-0.02 | $-0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2025 | May 7, 2025 | -11.5% | $0.33 | $0.33 | +0.00% |
| ▲ Q1 FY2025 | Mar 12, 2025 | +102.0% | $0.26 | $0.26 | +1.76% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +4.5% | $1.36 | $1.41 | +3.68% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +6.3% | $0.78 | $0.71 | -9.90% |
| ▼ Q2 FY2024 | May 9, 2024 | -21.9% | $1.26 | $1.29 | +2.38% |
| ▼ Q1 FY2024 | Mar 14, 2024 | -34.0% | $1.40 | $1.31 | -6.43% |
| ▼ Q4 FY2023 | Nov 13, 2023 | -13.0% | $1.79 | $1.80 | +0.56% |
| ▲ Q3 FY2023 | Aug 9, 2023 | +16.3% | $5.39 | $4.90 | -9.09% |
Q2 FY2025+0.00%
Report Date
May 7, 2025
EPS Beat/Miss
-11.5%
Price Before
$0.33
Price After
$0.33
Q1 FY2025+1.76%
Report Date
Mar 12, 2025
EPS Beat/Miss
+102.0%
Price Before
$0.26
Price After
$0.26
Q4 FY2024+3.68%
Report Date
Nov 6, 2024
EPS Beat/Miss
+4.5%
Price Before
$1.36
Price After
$1.41
Q3 FY2024-9.90%
Report Date
Aug 7, 2024
EPS Beat/Miss
+6.3%
Price Before
$0.78
Price After
$0.71
Q2 FY2024+2.38%
Report Date
May 9, 2024
EPS Beat/Miss
-21.9%
Price Before
$1.26
Price After
$1.29
Q1 FY2024-6.43%
Report Date
Mar 14, 2024
EPS Beat/Miss
-34.0%
Price Before
$1.40
Price After
$1.31
Q4 FY2023+0.56%
Report Date
Nov 13, 2023
EPS Beat/Miss
-13.0%
Price Before
$1.79
Price After
$1.80
Q3 FY2023-9.09%
Report Date
Aug 9, 2023
EPS Beat/Miss
+16.3%
Price Before
$5.39
Price After
$4.90
Avg Beat Reaction-3.39%
Avg Miss Reaction-0.87%
Beat Rate4 / 8 quarters
Largest Move-9.90% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALLK ends December
Allakos Inc. (ALLK) most recently reported earnings on May 7, 2025 for Q2 FY2025, posting EPS of $-0.29 — missing the analyst consensus of $-0.26 by -11.5%. The next ALLK earnings date is expected around September 1, 2026.
Each quarter, investors track ALLK earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALLK revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALLK's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALLK earnings · 5 questionsAllakos Inc.'s next earnings report is expected around September 1, 2026. ALLK typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALLK historically reports after market close (AMC).
ALLK earnings datewhen is ALLK earningsALLK next earnings datewhen does ALLK report earningsALLK earnings calendar
▸ Source: FMP · Allakos Inc. SEC filings · US GAAP · Allakos Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026